| Product Code: ETC6748426 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Nephrogenic Diabetes Insipidus Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Nephrogenic Diabetes Insipidus Market Revenues & Volume, 2021 & 2031F |
3.3 China Nephrogenic Diabetes Insipidus Market - Industry Life Cycle |
3.4 China Nephrogenic Diabetes Insipidus Market - Porter's Five Forces |
3.5 China Nephrogenic Diabetes Insipidus Market Revenues & Volume Share, By Symptoms, 2021 & 2031F |
3.6 China Nephrogenic Diabetes Insipidus Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.7 China Nephrogenic Diabetes Insipidus Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 China Nephrogenic Diabetes Insipidus Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 China Nephrogenic Diabetes Insipidus Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of nephrogenic diabetes insipidus in China |
4.2.2 Growing investments in healthcare infrastructure and research for rare diseases |
4.2.3 Rising prevalence of risk factors such as genetic disorders and certain medications |
4.3 Market Restraints |
4.3.1 Limited treatment options and high costs associated with managing nephrogenic diabetes insipidus |
4.3.2 Lack of skilled healthcare professionals specialized in treating the condition in China |
4.3.3 Regulatory challenges and slow approval processes for new treatments |
5 China Nephrogenic Diabetes Insipidus Market Trends |
6 China Nephrogenic Diabetes Insipidus Market, By Types |
6.1 China Nephrogenic Diabetes Insipidus Market, By Symptoms |
6.1.1 Overview and Analysis |
6.1.2 China Nephrogenic Diabetes Insipidus Market Revenues & Volume, By Symptoms, 2021- 2031F |
6.1.3 China Nephrogenic Diabetes Insipidus Market Revenues & Volume, By Chronic Excessive Thirst (Polydipsia), 2021- 2031F |
6.1.4 China Nephrogenic Diabetes Insipidus Market Revenues & Volume, By Excessive Urine Production (Polyuria), 2021- 2031F |
6.1.5 China Nephrogenic Diabetes Insipidus Market Revenues & Volume, By Others, 2021- 2031F |
6.2 China Nephrogenic Diabetes Insipidus Market, By Drug Type |
6.2.1 Overview and Analysis |
6.2.2 China Nephrogenic Diabetes Insipidus Market Revenues & Volume, By Demeclocycline, 2021- 2031F |
6.2.3 China Nephrogenic Diabetes Insipidus Market Revenues & Volume, By Ofloxacin, 2021- 2031F |
6.2.4 China Nephrogenic Diabetes Insipidus Market Revenues & Volume, By Orlistat, 2021- 2031F |
6.3 China Nephrogenic Diabetes Insipidus Market, By Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 China Nephrogenic Diabetes Insipidus Market Revenues & Volume, By X-ray Scans, 2021- 2031F |
6.3.3 China Nephrogenic Diabetes Insipidus Market Revenues & Volume, By Computed Tomography (CT Scan), 2021- 2031F |
6.3.4 China Nephrogenic Diabetes Insipidus Market Revenues & Volume, By Ultrasound, 2021- 2031F |
6.3.5 China Nephrogenic Diabetes Insipidus Market Revenues & Volume, By Magnetic Resonance Imaging (MRI), 2021- 2031F |
6.4 China Nephrogenic Diabetes Insipidus Market, By End Users |
6.4.1 Overview and Analysis |
6.4.2 China Nephrogenic Diabetes Insipidus Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 China Nephrogenic Diabetes Insipidus Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 China Nephrogenic Diabetes Insipidus Market Revenues & Volume, By Pharmaceutical Companies, 2021- 2031F |
6.4.5 China Nephrogenic Diabetes Insipidus Market Revenues & Volume, By Others, 2021- 2031F |
7 China Nephrogenic Diabetes Insipidus Market Import-Export Trade Statistics |
7.1 China Nephrogenic Diabetes Insipidus Market Export to Major Countries |
7.2 China Nephrogenic Diabetes Insipidus Market Imports from Major Countries |
8 China Nephrogenic Diabetes Insipidus Market Key Performance Indicators |
8.1 Number of new diagnoses of nephrogenic diabetes insipidus in China |
8.2 Research and development investments in finding new treatment options |
8.3 Patient satisfaction and quality of life improvements with existing treatments |
9 China Nephrogenic Diabetes Insipidus Market - Opportunity Assessment |
9.1 China Nephrogenic Diabetes Insipidus Market Opportunity Assessment, By Symptoms, 2021 & 2031F |
9.2 China Nephrogenic Diabetes Insipidus Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.3 China Nephrogenic Diabetes Insipidus Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.4 China Nephrogenic Diabetes Insipidus Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 China Nephrogenic Diabetes Insipidus Market - Competitive Landscape |
10.1 China Nephrogenic Diabetes Insipidus Market Revenue Share, By Companies, 2024 |
10.2 China Nephrogenic Diabetes Insipidus Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |